Evolution of the NCI antibody-drug conjugate portfolio: from chemical engineering to clinical complexity.
Saved in:
| Title: | Evolution of the NCI antibody-drug conjugate portfolio: from chemical engineering to clinical complexity. |
|---|---|
| Authors: | Zhan Q; Department of Breast Surgery, Pingxiang People's Hospital, Pingxiang, China., Zeng W; Fuzhou Medical College, Nanchang University, Fuzhou, China., Shi H; Fuzhou Medical College, Nanchang University, Fuzhou, China., Wan H; Department of Breast Surgery, Pingxiang People's Hospital, Pingxiang, China. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2026 Apr 02; Vol. 13, pp. 1773414. Date of Electronic Publication: 2026 Apr 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-858X |
|---|---|
| DOI: | 10.3389/fmed.2026.1773414 |
